POCI

Company Overview — What Does PRECISION OPTICS CORPORATION, INC. Do?

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies, which are designed for industrial and military use. The company markets its products to original equipment manufacturers through medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts. PRECISION OPTICS CORPORATION, INC. (POCI) is classified as a micro-cap stock in the Healthcare sector, specifically within the Medical Equipment industry. The company is led by CEO Joseph N. Forkey and employs approximately 80 people. With a market capitalization of $44M, POCI is one of the notable companies in the Healthcare sector.

PRECISION OPTICS CORPORATION, INC. (POCI) Stock Rating — Reduce (April 2026)

As of April 2026, PRECISION OPTICS CORPORATION, INC. receives a Reduce rating with a composite score of 37.5/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.POCI ranks #2,623 out of 4,446 stocks in our coverage universe. Within the Healthcare sector, PRECISION OPTICS CORPORATION, INC. ranks #346 of 838 stocks, placing it in the upper half of its Healthcare peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

POCI Stock Price and 52-Week Range

PRECISION OPTICS CORPORATION, INC. (POCI) currently trades at $4.17. The stock gained $0.18 (4.5%) in the most recent trading session. The 52-week high for POCI is $6.04, which means the stock is currently trading -31.0% from its annual peak. The 52-week low is $3.77, putting the stock 10.7% above its annual trough. Recent trading volume was 87K shares, suggesting relatively thin trading activity.

Is POCI Overvalued or Undervalued? — Valuation Analysis

PRECISION OPTICS CORPORATION, INC. (POCI) carries a value factor score of 29/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 4.57x, versus the sector average of 2.75x. The price-to-sales ratio is 1.87x, compared to 1.66x for the average Healthcare stock.

At current multiples, PRECISION OPTICS CORPORATION, INC. trades at a premium to most Healthcare peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

PRECISION OPTICS CORPORATION, INC. Profitability — ROE, Margins, and Quality Score

PRECISION OPTICS CORPORATION, INC. (POCI) earns a quality factor score of 27/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -69.5%, compared to the Healthcare sector average of -43.5%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -28.3% versus the sector average of -33.1%.

On a margin basis, PRECISION OPTICS CORPORATION, INC. reports gross margins of 12.6%, compared to 71.5% for the sector. The operating margin is -29.1% (sector: -66.1%). Net profit margin stands at -30.0%, versus -58.7% for the average Healthcare stock. Revenue growth is running at 75.5% on a trailing basis, compared to 10.6% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

POCI Debt, Balance Sheet, and Financial Health

PRECISION OPTICS CORPORATION, INC. has a debt-to-equity ratio of 17.0%, compared to the Healthcare sector average of 32.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 1.05x, suggesting adequate working capital coverage. Total debt on the balance sheet is $2M.

POCI has a beta of 0.17, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for PRECISION OPTICS CORPORATION, INC. is 60/100, reflecting average volatility within the normal range for its sector.

PRECISION OPTICS CORPORATION, INC. Revenue and Earnings History — Quarterly Trend

In TTM 2026, PRECISION OPTICS CORPORATION, INC. reported revenue of $23M and earnings per share (EPS) of $-0.23. Net income for the quarter was $-6M. Gross margin was 12.6%. Operating income came in at $-6M.

In Q2 2026, PRECISION OPTICS CORPORATION, INC. reported revenue of $7M and earnings per share (EPS) of $-0.23. Net income for the quarter was $-2M. Gross margin was 2.8%. Revenue grew 62.8% year-over-year compared to Q2 2025. Operating income came in at $-2M.

In Q1 2026, PRECISION OPTICS CORPORATION, INC. reported revenue of $7M and earnings per share (EPS) of $-0.21. Net income for the quarter was $-2M. Gross margin was 14.2%. Revenue grew 59.2% year-over-year compared to Q1 2025. Operating income came in at $-2M.

In FY 2025, PRECISION OPTICS CORPORATION, INC. reported revenue of $19M and earnings per share (EPS) of $-0.85. Net income for the quarter was $-6M. Gross margin was 17.8%. Revenue grew -0.1% year-over-year compared to FY 2024. Operating income came in at $-6M.

Over the past 8 quarters, PRECISION OPTICS CORPORATION, INC. has demonstrated a growth trajectory, with revenue expanding from $19M to $23M. Investors analyzing POCI stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

POCI Dividend Yield and Income Analysis

PRECISION OPTICS CORPORATION, INC. (POCI) does not currently pay a dividend. This is common among smaller companies in the Medical Equipment industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Healthcare dividend stocks may want to explore other Healthcare stocks or use the stock screener to filter by dividend yield.

POCI Momentum and Technical Analysis Profile

PRECISION OPTICS CORPORATION, INC. (POCI) has a momentum factor score of 40/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 22/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 68/100 reflects moderate short selling activity.

POCI vs Competitors — Healthcare Sector Ranking and Peer Comparison

Within the Healthcare sector, PRECISION OPTICS CORPORATION, INC. (POCI) ranks #346 out of 838 stocks based on the Blank Capital composite score. This places POCI in the upper half of all Healthcare stocks in our coverage universe. Key competitors and sector peers include ASTRAZENECA PLC (AZN) with a score of 61.4/100, Sol-Gel Technologies Ltd. (SLGL) with a score of 56.6/100, VIEMED HEALTHCARE, INC. (VMD) with a score of 53.4/100, Innoviva, Inc. (INVA) with a score of 52.7/100, and JOHNSON & JOHNSON (JNJ) with a score of 51.7/100.

Comparing POCI against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full POCI vs S&P 500 (SPY) comparison to assess how PRECISION OPTICS CORPORATION, INC. stacks up against the broader market across all factor dimensions.

POCI Next Earnings Date

No upcoming earnings date has been announced for PRECISION OPTICS CORPORATION, INC. (POCI) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy POCI? — Investment Thesis Summary

The quantitative profile for PRECISION OPTICS CORPORATION, INC. suggests caution. The quality score of 27/100 flags below-average profitability. The value score of 29/100 indicates premium valuation. Low volatility (stability score 60/100) reduces downside risk.

In summary, PRECISION OPTICS CORPORATION, INC. (POCI) earns a Reduce rating with a composite score of 37.5/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on POCI stock.

Related Resources for POCI Investors

Explore more research and tools: POCI vs S&P 500 comparison, top Healthcare stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare POCI head-to-head with peers: POCI vs AZN, POCI vs SLGL, POCI vs VMD.